The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.

Clevenger, Steven S; Malhotra, Devvrat; Dang, Jonathan; Vanle, Brigitte; IsHak, Waguih William

Clevenger, Steven S; Malhotra, Devvrat; Dang, Jonathan; Vanle, Brigitte; IsHak, Waguih William.

Afiliação

Clevenger SS; Western University of Health Sciences College of Osteopathic Medicine, and Cedars-Sinai Medical Center Department of Psychiatry, Los Angeles, CA, USA.
Malhotra D; Western University of Health Sciences College of Osteopathic Medicine, and Cedars-Sinai Medical Center Department of Psychiatry, Los Angeles, CA, USA.
Dang J; Cedars-Sinai Medical Center Department of Psychiatry, Los Angles, CA, USA.
Vanle B; Cedars-Sinai Medical Center Department of Psychiatry, Los Angles, CA, USA.
IsHak WW; Cedars-Sinai Medical Center Department of Psychiatry and UCLA, 8730 Alden Drive, Thalians E-132, Los Angeles, CA 90048-0750, USA.

Ther Adv Psychopharmacol ; 8(1): 49-58, 2018 Jan.

Article em En | MEDLINE | ID: mdl-29344343

Palavras-chave

MDD prevention; MDD prophylaxis; SSRI; antidepressants; depression; major depression; major depressive disorder; specific serotonin reuptake inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article